Alnylam Pharmaceuticals
Patent Applications and Registrations
Patent applications and USPTO patent grants for Alnylam Pharmaceuticals.The latest application filed is for "microrna compositions and methods".
- Alnylam Pharmaceuticals - Cambridge MA
- Alnylam Pharmaceuticals - 300 Third Street Cambridge MA
- Alnylam Pharmaceuticals - Mayo Foundation for Medical Education and Resear
| Patent | Date |
|---|---|
| Compositions and methods for inhibiting expression of CD274/PD-L1 gene Grant 9,422,562 - DeFougerolles , et al. August 23, 2 | 2016-08-23 |
| Serpinc1 iRNA compositions and methods of use thereof Grant 9,127,274 - Akinc , et al. September 8, 2 | 2015-09-08 |
| Microrna Compositions And Methods App 20150087607 - Marcusson; Eric G. ; et al. | 2015-03-26 |
| SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF App 20130317081 - Akinc; Akin ; et al. | 2013-11-28 |
| Process For Synthesizing Oligonucleotide Phosphate Derivatives App 20110282044 - MANOHARAN; Muthiah ; et al. | 2011-11-17 |
| Therapeutic Compositions App 20110201798 - MANOHARAN; Muthiah | 2011-08-18 |
| Chemically Modified Oligonucleotides And Uses Thereof App 20110065774 - Manoharan; Muthiah | 2011-03-17 |
| Therapeutic Compositions App 20110054160 - Manoharan; Muthiah ; et al. | 2011-03-03 |
| MODIFIED iRNA AGENTS App 20100292455 - MANOHARAN; Muthiah ; et al. | 2010-11-18 |
| Double-stranded Ribonucleic Acid With Increased Effectiveness In An Organism App 20100280102 - Woppmann; Claudia ; et al. | 2010-11-04 |
| Compostions and methods for enhancing oligonucleotide delivery across and into epithelial tissues App 20100222417 - Zimmermann; Tracy ; et al. | 2010-09-02 |
| Oligonucleotides comprising a modified or non-natural nucleobase Grant 7,772,387 - Manoharan , et al. August 10, 2 | 2010-08-10 |
| MODIFIED iRNA AGENTS App 20100179309 - MANOHARAN; Muthiah ; et al. | 2010-07-15 |
| IRNA agents with biocleavable tethers Grant 7,723,509 - Manoharan , et al. May 25, 2 | 2010-05-25 |
| Oligonucleotides comprising a non-phosphate backbone linkage Grant 7,723,512 - Manoharan , et al. May 25, 2 | 2010-05-25 |
| Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine Grant 7,674,778 - Manoharan , et al. March 9, 2 | 2010-03-09 |
| Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety Grant 7,626,014 - Manoharan , et al. December 1, 2 | 2009-12-01 |
| Double-Stranded Ribonucleic Acid with Increased Effectiveness in an Organism App 20070275465 - Woppmann; Claudia ; et al. | 2007-11-29 |
| Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase App 20070054279 - Manoharan; Muthiah ; et al. | 2007-03-08 |
| Method of treating neurodegenerative disease App 20050186591 - Bumcrot, David ; et al. | 2005-08-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 